SEC Form 4 · accession 0001209191-16-094138
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joshua S Boger
Director
Period of report
Jan 27, 2016
Accepted (ET)
Jan 29, 2016 · 4:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 27, 2016 | M | 11,200 | $35.64 | A | 276,484 | D | |
| Common StockF2,F3 | Jan 27, 2016 | S | 700 | $90.70 | D | 275,784 | D | |
| Common StockF3,F4 | Jan 27, 2016 | S | 3,300 | $92.04 | D | 272,484 | D | |
| Common StockF3,F5 | Jan 27, 2016 | S | 2,400 | $93.00 | D | 270,084 | D | |
| Common StockF3,F6 | Jan 27, 2016 | S | 2,600 | $94.10 | D | 267,484 | D | |
| Common StockF3,F7 | Jan 27, 2016 | S | 2,100 | $94.94 | D | 265,384 | D | |
| Common Stock | Jan 27, 2016 | S | 100 | $95.71 | D | 265,284 | D | |
| Common Stock | holding | — | — | — | 13,286 | I | 401k | |
| Common Stock | holding | — | — | — | 122,700 | I | Common Stock Held in Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F8 | $35.64 | Jan 27, 2016 | M | 11,200 | D | — | Feb 1, 2016 | Common Stock | 11,200 | 0 | D |
Explanation of responses
- F1Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
- F2Open market sales reported on this line occurred at a weighted average price of $90.70 (range $90.57 to $91.23).
- F3Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- F4Open market sales reported on this line occurred at a weighted average price of $92.04 (range $91.61 to $92.60).
- F5Open market sales reported on this line occurred at a weighted average price of $93.00 (range $92.61 to $93.51).
- F6Open market sales reported on this line occurred at a weighted average price of $94.10 (range $93.63 to $94.53).
- F7Open market sales reported on this line occurred at a weighted average price of $94.94 (range $94.65 to $95.31).
- F8Fully vested.